News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novacea, Inc. (NOVC) and Transcept Pharmaceuticals, Inc. Announce Filing of Form S-4 Proxy/Registration Statement


10/6/2008 9:27:15 AM

SOUTH SAN FRANCISCO, CA and POINT RICHMOND, CA--(Marketwire - October 06, 2008) - Novacea, Inc. (NASDAQ: NOVC) and Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that on October 3, 2008, Novacea filed its Registration Statement on Form S-4 with the Securities and Exchange Commission (SEC) in connection with its proposed merger with Transcept. The definitive merger agreement was entered into on August 29, 2008.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES